During the past decade, The Affiliated Hospital of Qingdao University conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 14 clinical trials were completed, i.e. on average, 7.6% percent of trials that started reached the finish line to date. In the past 5 years, 124 clinical trials started and 11 clinical trials were completed. i.e. 8.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Affiliated Hospital of Qingdao University" #1 sponsor was "The Affiliated Hospital of Qingdao University" with 33 trials, followed by "Qingdao University" with 13 trials sponsored, "BeiGene" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Jiangsu HengRui Medicine Co., Ltd." with 6 trials sponsored. Other sponsors include 145 different institutions and companies that sponsored additional 111 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital of Qingdao University" #1 collaborator was "The Affiliated Hospital of Qingdao University" with 10 trials as a collaborator, "Chinese PLA General Hospital" with 5 trials as a collaborator, "Fujian Medical University Union Hospital" with 5 trials as a collaborator, "Ruijin Hospital" with 5 trials as a collaborator and "Shandong Provincial Hospital" with 5 trials as a collaborator. Other collaborators include 340 different institutions and companies that were collaborators in the rest 239 trials.

According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital of Qingdao University" are "Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Healthy" (4 trials), "Mesenchymal Stem Cells" (4 trials) and "Non-small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "The Affiliated Hospital of Qingdao University" in a lesser frequency.

Most popular intervention types in "The Affiliated Hospital of Qingdao University" are "Drug" (128 trials), "Other" (21 trials), "Device" (18 trials), "Procedure" (16 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Tislelizumab" (7 trials), "Docetaxel" (5 trials), "Capecitabine" (4 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "The Affiliated Hospital of Qingdao University" are 199 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 107 active trials in "The Affiliated Hospital of Qingdao University". 14 are not yet recruiting, 70 are recruiting, 20 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 62 completed trials in The Affiliated Hospital of Qingdao University, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in The Affiliated Hospital of Qingdao University, 41 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 35 trials that are defined as “Not Applicable".